Due to the revision of the Soarnol\u2122 UK plant investment plan, an impairment loss of approximately 30 billion yen is scheduled to be recorded in the fiscal year ending March 2026. The investment amount has increased and construction delays have occurred, resulting in expected decreased profitability.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4188","jir_company_name":"Mitsubishi Chemical Group Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-04-22","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/4188-20260422-01.pdf","jir_short_summary":"Due to the revision of the Soarnol\u2122 UK plant investment plan, an impairment loss of approximately 30 billion yen is scheduled to be recorded in the fiscal year ending March 2026. The investment amount has increased and construction delays have occurred, resulting in expected decreased profitability.","jir_summary":"### Overview of Investment Plan Revision\nMitsubishi Chemical UK Limited, a consolidated subsidiary of Mitsubishi Chemical Group, manufactures and sells the ethylene vinyl alcohol copolymer resin \"Soarnol\u2122.\" Due to increased complexity in design and construction as well as global inflation driving higher material and labor costs, construction expenses have exceeded initial estimates, and delays in the construction schedule have occurred, leading to a decision to increase the investment amount. The new production facilities are scheduled to start operation in fiscal year 2027.\n\n### Impact on Performance and Future Response\nProfitability is expected to decline due to the increased investment amount, and an impairment loss of approximately 30 billion yen is scheduled to be recorded in the fiscal year ending March 2026. This impairment loss was not reflected in the earnings guidance announced on February 5, 2026, and the necessity for revising future earnings guidance is currently under review. The \"Soarnol\u2122\" product remains positioned as a growth driver for the company and retains its importance as a material supporting food quality preservation.","jir_financial_highlights":"Impairment Loss: Approximately 30 billion yen (Unknown)\nRevenue (Forecast for FY March 2026): 3,672,000 million yen (Unknown)\nCore Operating Income (Forecast for FY March 2026): 250,000 million yen (Unknown)","jir_category":"","jir_hashtags":"#MitsubishiChemicalGroup, #general_ir, #JapaneseStocks","jir_key_figures":"Impairment Loss: Approximately 30 billion yen (Scheduled to be recorded in FY March 2026)\nRevenue Forecast: 3,672,000 million yen (FY March 2026)\nCore Operating Income Forecast: 250,000 million yen (FY March 2026)","jir_meta_title":"\u3010Mitsubishi Chemical Group\u3011Review of Soarnol Investment Plan Results in Approx. 30 Billion Yen Impairment | April 2026","jir_meta_description":"Mitsubishi Chemical Group has revised the investment plan for its Soarnol manufacturing facilities in the UK, recording an impairment loss of approximately 30 billion yen in the fiscal year ending March 2026 due to construction delays and cost overruns. The impact on profitability is currently being analyzed.","jir_og_title":"\u3010Mitsubishi Chemical Group\u3011Approx. 30 Billion Yen Impairment Due to Revision of Soarnol Investment Plan","jir_og_description":"Following the revision of the Soarnol facility investment in the UK, an impairment loss of approximately 30 billion yen is planned to be recorded. The impact on profitability is currently under detailed review.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7488,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-41781","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n